<DOC>
	<DOCNO>NCT00413660</DOCNO>
	<brief_summary>The purpose study determine effectiveness safety , 6 month , 6 dose regimen CP-690,550 , combine methotrexate , treatment adult active rheumatoid arthritis .</brief_summary>
	<brief_title>Comparison Of 6 CP-690,550 Doses Vs.Placebo , Each Combined With Methotrexate , For The Treatment Of Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Tofacitinib</mesh_term>
	<criteria>Active rheumatoid arthritis Inadequate response stably dose methotrexate Current therapy DMARD biologic methotrexate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>DMARD therapy</keyword>
</DOC>